ANGELICA MILLER: Open Payments
NPI 1346714094 · MARIETTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$5,876 in 98 payments from 32 companies in 2025. Trend: 2023 $2,558 · 2024 $5,514 · 2025 $5,876
Food & beverage: $2,582Consulting: $2,070Travel & lodging: $1,006Education: $218
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 8 | $3,361 |
| Janssen Biotech, Inc. | 7 | $338 |
| BeOne Medicines USA, Inc. | 5 | $206 |
| Novartis Pharmaceuticals Corporation | 10 | $195 |
| PFIZER INC. | 11 | $195 |
| AstraZeneca Pharmaceuticals LP | 7 | $176 |
| Incyte Corporation | 4 | $159 |
| E.R. Squibb & Sons, L.L.C. | 2 | $144 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $118 |
| Alexion Pharmaceuticals, Inc. | 4 | $102 |
Products named: SARCLISA, REBLOZYL, BRUKINSA, ERLEADA, RYBREVANT, Jakafi, ULTOMIRIS, SCEMBLIX.
Industry payments across GA — which companies pay providers there.
